N/A
Completed N=4,774
Pragmatic, Randomized Evaluation of Statin Active Choice to Reach Improved Outcomes Based on Evidence
Source: ClinicalTrials.gov NCT03021759 ↗Enrolled (actual)
4,774
Serious AEs
0.0%
Results posted
Jun 2019
Primary outcomePrimary: Statin Prescribing Rate — 40; 116; 117 Participants
Summary
In this study, the investigators will conduct a pragmatic, cluster-randomized, controlled trial to evaluate an active choice intervention with and without social comparison feedback to increase physician statin prescribing rates for eligible patients.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Statin Prescribing Rate |
40; 116; 117 | — |
Eligibility Criteria
Inclusion Criteria
- Patient has a primary care physician at University of Pennsylvania Health System
- Patient meets 2013 AHA/ACC guidelines for statin therapy but no record of a statin prescription in the electronic health record
Exclusion Criteria
- Patient has an allergy or adverse reaction to statins documented in the electronic health record
- Patient has glomerular filtration rate less than 30 mL/min
- Physicians (and their respective patients) will be excluded if they have less than 10 patients among their entire panel that are eligible for a statin
Data sourced from ClinicalTrials.gov (NCT03021759). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.